Join a conversation with philanthropists, researchers, industry and government. Delivering impact from medical research.
In order to harness the benefits from medical research it is important to bring all key stakeholders together, including philanthropy, industry, government and academia. NFMRI’s conference uniquely provides this opportunity, creating an interactive forum to discuss opportunities, issues and ideas. We encourage delegates to submit questions in advance and contribute to the conversation. The […]VIEW POST
The ‘halo effect’ can be both a positive and negative for funders of research. How does it affect you?
A challenge for funders of research is that it often requires more than research to achieve their ultimate goals. Restricting funding to research is often set out in the terms of; a bequest, a donation, a grant, the constitution and may be a requirement for the funder to maintain charitable status. The outcome funders wish […]VIEW POST
This Christmas we have decided to try something new for our family. An experiment that I hope may turn into a family tradition. I hope it will help bring the family together in years to come, create an opportunity for thoughtful discussion, create opportunities to learn about each other, from each other and to contribute […]VIEW POST
Mr Keith Drewery chaired the panel session at the NFMRI conference “Supporting biomedical research projects: where are we now and where are we headed?” Chair: Keith Drewery Panelists: Caitriona Fay, Perpetual Private Wealth; Christopher Thorn, Evans & Partners; Gina Anderson, GDI Funds Management and Nancy Ranner, NFMRI.VIEW POST
The process of applying for grants has never been uniform or easy. Different foundations or funding bodies have different processes, rules, guidelines and eligibility requirements. That being said, hopefully the following considerations will help: Do your homework This sounds simple, but in reality so many applicants don’t take the small amount of time required […]VIEW POST
Do funders of research have a responsibility to consider their role in lowering the level of irreproducible results?
I have touched on this topic briefly in some of our other posts, [e.g. 1, 2 & 3] but following a recent discussion I decided to explore the topic of irreproducible results further and encourage conversation. During a recent discussion I was told that researchers with a well-established quality system in place were considering dropping […]VIEW POST
The future funding of medical research: it’s not only about what, and to whom, but also about how support can be applied?
Our previous post identified a simplified three-dimensional puzzle to help identify support strategies including; Disease(s) or condition(s), The field(s) of research, and The translational pathway(s) to deliver impact Applying this strategy by taking into account your internal expertise, capability and capacity, and the wider supporting ecosystem (including funding and access to facilities, expertise and translational […]VIEW POST
Determining what success might look like is fundamental to developing strategy. Success for funders of research is of course not only about the outcomes of the research they fund, but also about the success of their own organisations. Reviewing an organisation’s position within the changing future funding of medical research ecosystem includes identifying opportunity, risk […]VIEW POST
In our last post, we mentioned failure and how grant makers should not only have a way around measuring success for grants that worked to plan, but also for grants that haven’t. We thought this topic should be explored in a little more detail. Research by its nature has the ability to fail. Researchers take […]VIEW POST
Grants in medical research: you’re likely receiving them, awarding them or chasing them. If you are in a position where you’re awarding them, then there is a likely chance that you chose to award them to projects that fit within a particular cause or focus area of interest. For many funders with open grant rounds, […]VIEW POST